UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertension

The European respiratory journal, 2004-12, Vol.24 (6), p.1007-1010

2004

Volltextzugriff (PDF)

Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids

The European respiratory journal, 2003-08, Vol.22 (2), p.330-334

2003

Volltextzugriff (PDF)

"Treat-to-target" in pulmonary arterial hypertension and the use of extracorporeal membrane oxygenation as a bridge to transplantation

European respiratory review, 2011-12, Vol.20 (122), p.297-300

Hoeper, M M

2011

Volltextzugriff (PDF)

Anticoagulant Therapy Is Not Associated with Long Term Outcome in Patients with Pulmonary Arterial Hypertension (PAH): Insights from the GRIPHON Study

The Journal of heart and lung transplantation, 2016-04, Vol.35 (4), p.S120-S120

2016

Volltextzugriff (PDF)

OP0267 Initial Combination Therapy of Ambrisentan and Tadalafil in Connective Tissue Disease Associated Pulmonary Arterial Hypertension (CTD-PAH): Subgroup Analysis from the Ambition Trial

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.173-173

2015

Volltextzugriff (PDF)

PP-372 Characteristics of Adults with Congenital Heart Disease and Pulmonary Arterial Hypertension in the COMPERA-CHD Registry

The American journal of cardiology, 2014-04, Vol.113 (7), p.S109-S110

2014

Volltextzugriff (PDF)

Pulmonary hypertension in collagen vascular disease

The European respiratory journal, 2002-03, Vol.19 (3), p.571-576

Hoeper, M.M

2002

Volltextzugriff (PDF)

Symptom Burden and Health Related Quality of Life in Patients With Idiopathic Pulmonary Fibrosis in Clinical Practice: Insights-Ipf Registry

Value in health, 2014-11, Vol.17 (7), p.A600-A600

2014

Volltextzugriff (PDF)

Ultrasonic versus jet nebulization of iloprost in severe pulmonary hypertension

The European respiratory journal, 2001-01, Vol.17 (1), p.14-19

2001

Volltextzugriff (PDF)

Extracorporeal Membrane Oxygenation in Nonintubated Patients as Bridge to Lung Transplantation

American journal of transplantation, 2010-09, Vol.10 (9), p.2173-2178

2010

Volltextzugriff (PDF)

Effects of inhaled salbutamol in primary pulmonary hypertension

The European respiratory journal, 2002-09, Vol.20 (3), p.524-528

2002

Volltextzugriff (PDF)

Bridge to Thoracic Organ Transplantation in Patients with Pulmonary Arterial Hypertension Using a Pumpless Lung Assist Device

American journal of transplantation, 2009-04, Vol.9 (4), p.853-857

2009

Volltextzugriff (PDF)

Chronic thromboembolic pulmonary hypertension: evaluation with 64-detector row CT vs. digital subtraction angiography

Clinical imaging, 2010-01, Vol.34 (1), p.78-78

2010

Volltextzugriff (PDF)

(16) - Waitlist Stratification and Outcomes in Lung Transplantation for Severe Pulmonary Hypertension

The Journal of heart and lung transplantation, 2024-04, Vol.43 (4), p.S17-S17

2024

Volltextzugriff (PDF)

Analysis of Risk Assessment Tools in the REPLACE Study

The Journal of heart and lung transplantation, 2021-04, Vol.40 (4), p.S465-S465

2021

Volltextzugriff (PDF)

Plasmaaustausch im therapierefraktären septischen Schock: Vorstellung einer Add-on-Therapiestrategie

Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2017-02, Vol.112 (1), p.42-46

2017

Volltextzugriff (PDF)

423: Avoiding Mechanical Ventilation during Extracorporeal Membrane Oxygenation before Lung Transplantation Decreases Postoperative Mortality

The Journal of heart and lung transplantation, 2010-02, Vol.29 (2), p.S140-S140

2010

Volltextzugriff (PDF)

Long-term outcomes in newly diagnosed pulmonary arterial hypertension (PAH) patients receiving initial triple oral combination therapy: insights from the randomised controlled TRITON study

European heart journal, 2020-11, Vol.41 (Supplement_2)

2020

Volltextzugriff (PDF)

Suppressor of Tumorigenicity 2 as a Biomarker in Pulmonary Arterial Hypertension and its Association with REVEAL Risk Score in Riociguat-Treated Patients in the RESPITE Study

The Journal of heart and lung transplantation, 2019-04, Vol.38 (4), p.S96-S96

2019

Volltextzugriff (PDF)

Risikostratifizierung und Verlaufskontrollen bei PAH-Patienten: Empfehlungen der Kölner Konsensus-Konferenz 2016

Deutsche medizinische Wochenschrift, 2016-10, Vol.141 (S 01), p.S19-S25

2016

Volltextzugriff (PDF)

(161) - Consistency of the Efficacy and Safety Profile of Sotatercept across Baseline Cardiac Index Subgroups: A Pooled Analysis of STELLAR and PULSAR Trials

The Journal of heart and lung transplantation, 2024-04, Vol.43 (4), p.S87-S87

2024

Volltextzugriff (PDF)

Initial Triple Oral Therapy in Pulmonary Arterial Hypertension (PAH): Extended Long-Term Outcome Data from TRITON

The Journal of heart and lung transplantation, 2021-04, Vol.40 (4), p.S108-S108

2021

Volltextzugriff (PDF)

Validation of REVEAL Risk Score Calculator 2.0 in Patients with CTEPH in the Phase III CHEST Study

The Journal of heart and lung transplantation, 2020-04, Vol.39 (4), p.S32-S33

2020

Volltextzugriff (PDF)

Validation of REVEAL Risk Score Calculator 2.0 in Patients with PAH in the Phase III PATENT Study

The Journal of heart and lung transplantation, 2020-04, Vol.39 (4), p.S18-S18

2020

Volltextzugriff (PDF)

Perioperative Extracorporeal Membrane Oxygenation-Based Protocol for Massive Acute Pulmonary Embolism

The Journal of heart and lung transplantation, 2019-04, Vol.38 (4), p.S337-S337

2019

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(50)
Buchkapitel
(3)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(15)
Life Sciences & Biomedicine
(15)
Science & Technology
(15)
Female
(12)
Biological And Medical Sciences
(11)
Male
(11)
Medical Sciences
(11)
Respiratory System
(11)
Pulmonary Hypertension
(9)
Adult
(8)
Middle Aged
(7)
Hypertension, Pulmonary - Drug Therapy
(6)
Hypertension, Pulmonary - Physiopathology
(6)
Internal Medicine
(6)
Medicine
(6)
Medicine & Public Health
(6)
Pharmacology. Drug Treatments
(6)
Administration, Inhalation
(5)
Drug Therapy, Combination
(5)
Hypertension
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertension

Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids

"Treat-to-target" in pulmonary arterial hypertension and the use of extracorporeal membrane oxygenation as a bridge to transplantation

Anticoagulant Therapy Is Not Associated with Long Term Outcome in Patients with Pulmonary Arterial Hypertension (PAH): Insights from the GRIPHON Study

OP0267 Initial Combination Therapy of Ambrisentan and Tadalafil in Connective Tissue Disease Associated Pulmonary Arterial Hypertension (CTD-PAH): Subgroup Analysis from the Ambition Trial

PP-372 Characteristics of Adults with Congenital Heart Disease and Pulmonary Arterial Hypertension in the COMPERA-CHD Registry

Pulmonary hypertension in collagen vascular disease

Symptom Burden and Health Related Quality of Life in Patients With Idiopathic Pulmonary Fibrosis in Clinical Practice: Insights-Ipf Registry

Ultrasonic versus jet nebulization of iloprost in severe pulmonary hypertension

Extracorporeal Membrane Oxygenation in Nonintubated Patients as Bridge to Lung Transplantation

Effects of inhaled salbutamol in primary pulmonary hypertension

Bridge to Thoracic Organ Transplantation in Patients with Pulmonary Arterial Hypertension Using a Pumpless Lung Assist Device

Chronic thromboembolic pulmonary hypertension: evaluation with 64-detector row CT vs. digital subtraction angiography

(16) - Waitlist Stratification and Outcomes in Lung Transplantation for Severe Pulmonary Hypertension

Analysis of Risk Assessment Tools in the REPLACE Study

Plasmaaustausch im therapierefraktären septischen Schock: Vorstellung einer Add-on-Therapiestrategie

423: Avoiding Mechanical Ventilation during Extracorporeal Membrane Oxygenation before Lung Transplantation Decreases Postoperative Mortality

Long-term outcomes in newly diagnosed pulmonary arterial hypertension (PAH) patients receiving initial triple oral combination therapy: insights from the randomised controlled TRITON study

Suppressor of Tumorigenicity 2 as a Biomarker in Pulmonary Arterial Hypertension and its Association with REVEAL Risk Score in Riociguat-Treated Patients in the RESPITE Study

Risikostratifizierung und Verlaufskontrollen bei PAH-Patienten: Empfehlungen der Kölner Konsensus-Konferenz 2016

(161) - Consistency of the Efficacy and Safety Profile of Sotatercept across Baseline Cardiac Index Subgroups: A Pooled Analysis of STELLAR and PULSAR Trials

Initial Triple Oral Therapy in Pulmonary Arterial Hypertension (PAH): Extended Long-Term Outcome Data from TRITON

Validation of REVEAL Risk Score Calculator 2.0 in Patients with CTEPH in the Phase III CHEST Study

Validation of REVEAL Risk Score Calculator 2.0 in Patients with PAH in the Phase III PATENT Study

Perioperative Extracorporeal Membrane Oxygenation-Based Protocol for Massive Acute Pulmonary Embolism

Suchergebnisse filtern